Patents by Inventor Min Jeoung SON

Min Jeoung SON has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • extracts, fractions or compounds isolated therefrom for the treatment or prevention of hyperuricemia or gout
    Patent number: 9527879
    Abstract: The present invention relates to an Aster glehni extract, a fraction thereof and the active compounds isolated therefrom, which are effective for the treatment, prevention and improvement of hyperuricemia or gout. The Aster glehni extract, the fraction thereof and 6?-O-caffeoylampelopsisionoside, 6?-O-caffeoylroseoside, 6?-O-caffeoylsonchuinoside C, 6?-O-caffeoyldihydrosyringin and glehnoside as the active compounds isolated from the fraction according to the present invention have substantial effect of inhibiting production of uric acid and decreasing its concentration. Accordingly, the Aster glehni extract, the fraction thereof and the active compounds isolated therefrom the fraction according to the present invention can be effectively used as an active ingredient of a drug, health food, etc. for the treatment, prevention and improvement of such as hyperuricemia or gout, which are diseases induced by increased level of uric acid.
    Type: Grant
    Filed: May 20, 2015
    Date of Patent: December 27, 2016
    Assignee: KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY
    Inventors: Hyoung Ja Kim, Chang Bae Jin, Min Jeoung Son, Yong Sup Lee, Chang Soo Yook, Jae Yeol Lee
  • ASTER GLEHNI EXTRACTS, FRACTIONS OR COMPOUNDS ISOLATED THEREFROM FOR THE TREATMENT OR PREVENTION OF HYPERURICEMIA OR GOUT
    Publication number: 20150337001
    Abstract: The present invention relates to an Aster glehni extract, a fraction thereof and the active compounds isolated therefrom, which are effective for the treatment, prevention and improvement of hyperuricemia or gout. The Aster glehni extract, the fraction thereof and 6?-O-caffeoylampelopsisionoside, 6?-O-caffeoylroseoside, 6?-O-caffeoylsonchuinoside C, 6?-O-caffeoyldihydrosyringin and glehnoside as the active compounds isolated from the fraction according to the present invention have substantial effect of inhibiting production of uric acid and decreasing its concentration. Accordingly, the Aster glehni extract, the fraction thereof and the active compounds isolated therefrom the fraction according to the present invention can be effectively used as an active ingredient of a drug, health food, etc. for the treatment, prevention and improvement of such as hyperuricemia or gout, which are diseases induced by increased level of uric acid.
    Type: Application
    Filed: May 20, 2015
    Publication date: November 26, 2015
    Inventors: Hyoung Ja KIM, Chang Bae JIN, Min Jeoung SON, Yong Sup LEE, Chang Soo YOOK, Jae Yeol LEE